%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

secondary-storefront-menu

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

mega-menu

footer-legal-menu-component

single-column

Browse by Institution Type

Browse by Product Type

Products

Support

products

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

footer-social-menu-component

Account Information

bundle-connector

cengage:galethorndikeseo

config

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

About Us

Blogs

Press Center

Events

News

Careers

Partnerships

Contact Us

Our Company

secondary-primary-menu

Request a Trial

zone2

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

zone3

header-component

footer-menu-component

gale-footer

container

secondary-account-menu

Profile

Orders

Wish List

Fast Order Entry

My Account

FIND YOUR REP

support-order-2

footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

footer-legal-menu

Terms of use

Privacy

header

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

zone1

footer

DEVALUED & DSTRSTD: PHRMCTCL IND RESTORE BROKEN IMAGE

Drugs & Pharmacology

Health, Medicine & Nursing

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

This book offers a balanced view of the role of drug discovery in improving public health. The pharmaceutical industry frequently receives criticism for things like promoting unsafe drugs and relying on a broken and irreparable R & D pipeline. The author, former Pfizer president John LaMattina, tackles some of these issues. He addresses the progress that industry has made in improving its abilities to measure both risk and benefits of its new medicines, then tackles the issue of R&D productivity - the reasons for the drop-off and whether it is temporary or permanent. Next, he discusses where the industry should invest its R&D resources and, of the multitude of solutions being offered to fix R&D, which are of value and how a company should proceed in the difficult business climate that is now facing. Finally, he presents ideas for how the industry can rehabilitate its image.

Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?

Library Adult

College Freshman

College Junior

College Sophomore

College Senior

Devalued and Distrusted

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Dedication.
Contents.
Acknowledgments.
Introduction.
1: The Four Secrets the Drug Companies Don&#x0027;t Want You to Know.
2: What Has Happened to R&#x0026;D Productivity?.
3: Key Therapeutic Areas For Improving Health.
4: Improving R&#x0026;D Output.
5: Restoring Pharma&#x0027;S Image.
6: Final Thoughts.
Index.

Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?.css-1p8rvzy{position:absolute;padding-left:8px;}

Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?